Home Newsfeeds Tesla Faces U.S. Criminal Probe Over Its Autopilot Technology; U.S. DOJ Probe Involves Company Claims That Tesla Cars Can Drive Themselves With Its Autopilot Activated

Tesla Faces U.S. Criminal Probe Over Its Autopilot Technology; U.S. DOJ Probe Involves Company Claims That Tesla Cars Can Drive Themselves With Its Autopilot Activated

-Reuters

byBenzinga Newsdesk

October 26, 2022

1 minute read

-Reuters

ClearPoint Neuro Congratulates Partner PTC Therapeutics On Being Granted Marketing Authorization By The European Commission For Upstaza – First Disease-Modifying Treatment For AADC Deficiency

By Benzinga Newsdesk

July 21, 4:24 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, congratulates partner PTC Therapeutics for being granted

CLPT

Phreesia Q3 EPS $(0.76) Misses $(0.61) Estimate, Sales $73.10M Beat $70.89M Estimate

By Bill Haddad

December 8, 5:03 PM

Phreesia (NYSE:PHR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.61) by 24.59 percent. This is a 65.22 percent decrease over losses of $(0.46) per share from the same

PHR

Polar Power Q2 EPS $(0.06) Up From $(0.07) YoY, Sales $4.20M Down From $4.85M YoY

By Bill Haddad

August 15, 4:50 PM

Polar Power (NASDAQ:POLA) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported $4.20 million in sales

POLA

Bitcoin Halving: Correction, Rally Or Market Top? Analyst Predicts ‘We Go Up From Here’

By Khyathi Dalal

February 1, 1:16 PM

The Bitcoin (CRYPTO: BTC) halving, scheduled for April 2024, has technical cryptocurrency analysts speculating about a bull run follow

BTC

Tesla Faces U.S. Criminal Probe Over Its Autopilot Technology; U.S. DOJ Probe Involves Company Claims That Tesla Cars Can Drive Themselves With Its Autopilot Activated

Related Posts

ClearPoint Neuro Congratulates Partner PTC Therapeutics On Being Granted Marketing Authorization By The European Commission For Upstaza – First Disease-Modifying Treatment For AADC Deficiency

Phreesia Q3 EPS $(0.76) Misses $(0.61) Estimate, Sales $73.10M Beat $70.89M Estimate

Polar Power Q2 EPS $(0.06) Up From $(0.07) YoY, Sales $4.20M Down From $4.85M YoY

Bitcoin Halving: Correction, Rally Or Market Top? Analyst Predicts ‘We Go Up From Here’